St Jude gains strong lead in quarter one as heart rivals suffer dent in profits
This article was originally published in Clinica
Shares in St Jude Medical hit a 12-month high after its first-quarter results shot ahead of analysts' expectations. Sales during the quarter climbed 13% $887m, bolstered by a strong performance from its major product lines, while favourable currency exchange rate gave an additional boost. Profits rose 6% to $146m, or $0.41 per share.
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.